financetom
Business
financetom
/
Business
/
Palantir Technologies Insider Sold Shares Worth $454,694, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Palantir Technologies Insider Sold Shares Worth $454,694, According to a Recent SEC Filing
Apr 4, 2024 7:22 AM

10:12 AM EDT, 04/04/2024 (MT Newswires) -- Alexander D. Moore, Director, on April 01, 2024, sold 20,000 shares in Palantir Technologies ( PLTR ) for $454,694. Following the Form 4 filing with the SEC, Moore has control over a total of 1,615,519 shares of the company, with 1,615,519 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1321655/000132165524000046/xslF345X03/wk-form4_1712188908.xml

Price: 23.26, Change: +0.56, Percent Change: +2.49

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Fisker Hires Advisers to Prepare for Possible Bankruptcy Filing
Market Chatter: Fisker Hires Advisers to Prepare for Possible Bankruptcy Filing
Mar 14, 2024
07:41 AM EDT, 03/14/2024 (MT Newswires) -- Fisker (FSR) has hired advisers to help prepare for a possible bankruptcy filing, The Wall Street Journal reported late Wednesday, citing people familiar with the matter. The company has hired financial adviser FTI Consulting and the law firm Davis Polk to work on a potential filing, the Journal reported. The electric vehicle startup...
HLS Therapeutics Reports Q4 2023 Net Loss of US$5.4 Million; Provides 2024 Outlook, Credit Agreement Update
HLS Therapeutics Reports Q4 2023 Net Loss of US$5.4 Million; Provides 2024 Outlook, Credit Agreement Update
Mar 14, 2024
07:37 AM EDT, 03/14/2024 (MT Newswires) -- HLS Therapeutics Inc. ( HLTRF ) , a pharmaceutical company focused on addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease, announced Thursday its Q4 2023 results (in US$).. The company reported product sales of $14.3 million, compared with $13.4 million, the year before. Royalty revenue was $15.9 million, up...
Athabasca Oil Reports Renewal of Normal Course Issuer Bid
Athabasca Oil Reports Renewal of Normal Course Issuer Bid
Mar 14, 2024
07:39 AM EDT, 03/14/2024 (MT Newswires) -- Athabasca Oil Corp. ( ATHOF ) said Thursday that it has secured approval from the Toronto Stock Exchange for the company's normal course issuer bid. The company plans to buy nearly 55.4 million common shares during the 12 months starting March 18, 2024, and ending March 17, 2025, or when completed or terminated....
Transat Widens Adjusted EPS YOY In Fiscal Q1
Transat Widens Adjusted EPS YOY In Fiscal Q1
Mar 14, 2024
07:41 AM EDT, 03/14/2024 (MT Newswires) -- Transat A.T. Inc. ( TRZBF ) , operating as an air carrier under the Air Transat brand, reported Thursday an adjusted net loss of $2.11 per share in the first quarter ended Jan. 31, 2024, widening from the year-ago loss of $1.62 per share. Revenue increased 17.7% to $785.5 million while adjusted EBITDA...
Copyright 2023-2026 - www.financetom.com All Rights Reserved